2019
DOI: 10.1007/s00066-019-01556-0
|View full text |Cite
|
Sign up to set email alerts
|

Low risk of contralateral lymph node recurrence in lateralized head and neck carcinoma after postoperative ipsilateral radiotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
14
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(14 citation statements)
references
References 25 publications
0
14
0
Order By: Relevance
“…Vergeer et al investigated 123 patients with oral cavity cancer (85%) and oropharyngeal cancer without contralateral neck irradiation and reported a cRF rate of 5.7% 18 ; however, their group included 7% of patients with close/cross midline disease, which could possibly increase the cRF. Wirtz et al reported a cRF rate of 6.1%, mainly in the oropharynx (52.8%), with extended data for oral cavity (38%) and hypopharynx (10%) 12 ; however, 73.1% of their patients received contralateral neck dissection, which could have been an overtreatment. Another phase II study demonstrated a low cRF rate of 2.8% for resected head and neck cancers.…”
Section: Discussionmentioning
confidence: 99%
“…Vergeer et al investigated 123 patients with oral cavity cancer (85%) and oropharyngeal cancer without contralateral neck irradiation and reported a cRF rate of 5.7% 18 ; however, their group included 7% of patients with close/cross midline disease, which could possibly increase the cRF. Wirtz et al reported a cRF rate of 6.1%, mainly in the oropharynx (52.8%), with extended data for oral cavity (38%) and hypopharynx (10%) 12 ; however, 73.1% of their patients received contralateral neck dissection, which could have been an overtreatment. Another phase II study demonstrated a low cRF rate of 2.8% for resected head and neck cancers.…”
Section: Discussionmentioning
confidence: 99%
“…To confirm these claims, prospective studies with follow-up of IMT, stenosis, and cerebrovascular events are needed to enable interventional trials for effective prevention (e.g. antiplatelet drugs, statins, H 2 S) [36][37][38][39].…”
Section: Discussionmentioning
confidence: 99%
“…In advanced-stage disease, i.e., UICC tumour stages III and IV, the combined therapeutical approach consisting of neck dissection followed by adjuvant radiation/chemoradiation is highly recommended as it yields the most favourable oncological outcomes [ 10 , 11 , 12 , 13 , 14 ]. In contrast, for early stage disease, i.e., UICC tumour stages I and II, the most effective therapy, i.e., ipsilateral selective neck dissection followed by radiation therapy or chemoradiation and primary radiation/chemoradiation therapy, is still under debate [ 15 ].…”
Section: Introductionmentioning
confidence: 99%